Evidence map›Paper›PMID 42851582›Full record

ArticleSmall science2026

[60]Fullerene-Cluster Hybrids as Boron-Dense Delivery Nanoplatforms.

Jennifer Patino-Alonso, Mónica Muñoz-Úbeda, Iván López-Montero, M José Ruiz-Magaña, Carmen Ruiz-Ruiz, Ignacio Porras, Miquel Nuez-Martínez, Rosario Núñez, Beatriz M Illescas, Justo Cabrera-González and 1 more

Abstract read
In one paragraph

Article in Small science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jennifer Patino-AlonsoDepartamento de Química Orgánica Facultad de Química Universidad Complutense Madrid Spain.
Mónica Muñoz-ÚbedaDepartamento de Química Física Facultad de Química Universidad Complutense Madrid Spain.ORCID https://orcid.org/0000-0001-9867-3614
Iván López-MonteroDepartamento de Química Física Facultad de Química Universidad Complutense Madrid Spain.ORCID https://orcid.org/0000-0001-8131-6063
M José Ruiz-MagañaInstituto de Biopatología y Medicina Regenerativa Centro de Investigación Biomédica Universidad de Granada Granada Spain.
Carmen Ruiz-RuizInstituto de Biopatología y Medicina Regenerativa Centro de Investigación Biomédica Universidad de Granada Granada Spain.
Ignacio PorrasDepartamento de Física Atómica, Molecular y Nuclear Facultad de Ciencias Universidad de Granada Granada Spain.
Miquel Nuez-MartínezInstitut de Ciència de Materials de Barcelona (ICMAB-CSIC) Cerdanyola del Vallès Spain.
Rosario NúñezInstitut de Ciència de Materials de Barcelona (ICMAB-CSIC) Cerdanyola del Vallès Spain.ORCID https://orcid.org/0000-0003-4582-5148
Beatriz M IllescasDepartamento de Química Orgánica Facultad de Química Universidad Complutense Madrid Spain.ORCID https://orcid.org/0000-0002-4727-8291
Justo Cabrera-GonzálezDepartamento de Química Orgánica Facultad de Química Universidad Complutense Madrid Spain.ORCID https://orcid.org/0000-0002-7733-9681
Nazario MartínDepartamento de Química Orgánica Facultad de Química Universidad Complutense Madrid Spain.ORCID https://orcid.org/0000-0002-5355-1477

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Boron Neutron Capture Therapy (BNCT) relies on the accumulation of boron-10 within tumor cells to induce highly localized cytotoxicity upon neutron irradiation. The development of boron delivery systems with high boron content, biocompatibility, and efficient cellular uptake remains a critical challenge. Herein, we report the design and synthesis of unprecedented fullerene-boron cluster hybrids that integrate the multivalent scaffold of [60]fullerene with anionic boron clusters. Two [60]fullerene hexakis-adducts bearing twelve peripheral cobaltabisdicarbollide (COSAN) or

Indexed as

BNCTboron clusterscarbon nanostructuresfullerenesmolecular materialsnanomedicine

Identifiers

PMID42851582
PMCPMC13646491

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.